Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies. [electronic resource]
Producer: 20080417Description: S12-9 p. digitalISSN:- 1530-6550
- Acute Coronary Syndrome -- blood
- Angioplasty, Balloon, Coronary -- adverse effects
- Aspirin -- pharmacology
- Biomarkers -- blood
- Blood Platelets -- drug effects
- Combined Modality Therapy
- Drug Therapy, Combination
- Humans
- Myocardial Infarction -- etiology
- Patient Selection
- Platelet Aggregation Inhibitors -- pharmacology
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Pyridines -- pharmacology
- Randomized Controlled Trials as Topic
- Risk Assessment
- Risk Factors
- Treatment Outcome
- Troponin -- blood
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.